MISTR Celebrates One Year of Free DoxyPEP With STI Positivity Rates Cut in Half

Just in time for STI Awareness Week (April 13th-19th). MISTR (USA’s largest LGBTQ+ sexual health platform) marks a game-changing milestone. It is a year of free doxipep to patients nationwide.

And what about the outcome? A dramatic 50% drop in STI positivity rate among users.

Since launching access to free Doxypep (post-exposure prophylaxis of Doxycyline) in 2024, Misttr has seen massive adoption. Currently, over 74% of patients require Doxypep bundled with PREP prescriptions, indicating a growing awareness and demand for this powerful STI prevention tool.

“Science is clear. Doxypep works. Preparation works. The problem is not recognition, it’s access,” he said. Mist Tor Founder and CEO Tristan Schukraft. “We’ve built a platform that patients really want to use. We’ve deleted stigmas, waiting rooms, paperwork, and we’ve seen the real results.”

Breaking barriers to care

Mist Tor It currently serves more than half a million patients in all 50 states, Washington, DC, and Puerto Rico, offering free online access to PREP, DOXYPEP, long-term HIV care, and home-based STI testing in both English and Spanish.

Through the TeleHealth model, Misttr has significantly expanded access to underserved communities, particularly in southern and black and Latino groups. This is a group that continues to face disproportionate rates of HIV and other STIs.

According to the Centers for Disease Control and Prevention (CDC):

• Over 68 million people in the US have STIs at any time.
• Only 2.4 million cases were officially reported in 2023.
• Currently, one in four people at risk for HIV is prescribed PREP.
• Among Black Americans most affected by the new HIV diagnosis, only 13% of eligible individuals are in preparation.

By comparison, black patients account for 18% of Mistr’s user base.

“If care is accessible, positive and there’s no stigma, it reaches the community that needs it most,” Schcraft said.

A new era of prevention

Carl Schmid, executive director of the Institute for HIV+Hepatitis Policy; Mist TorProgress of “Blueprint for what is possible.”

“The results of Misttr show what happens when you remove barriers and actually bring prevention where people are,” he said. “It’s a kind of innovation we need. It’s community-driven, tech-ready, stigma-free.”

Beyond digital care, Misttr works with over 65 nonprofit organizations to fund uninsured care and provide culturally competent sexual positivity services on a large scale. Its reach is closely aligned with the CDC’s preferred jurisdiction and federality Ending the HIV outbreak the goal.

Looking ahead

Next Generation Prevention – On the horizon, including long-acting injectable preparations, Mist Tor We are already preparing to integrate these options into the platform.

“We are expanding to reach everyone who wants protection but can’t or won’t be able to at the disadvantage of a broken health care system,” Schcraft said. “Prevention is stigma-free, the community is ingrained and it shows what is possible when it is actually convenient.”

As STI Awareness Week highlights the gap between rising infection rates and prevention, Mistr’s success stories provide timely reminders. When care is easily accessible, people show up and stay healthy.

Misttr celebrates one year of free doxipepe by reducing STI positivity rates in half